» 全部 » 库存预测 » Supernus Pharmaceuticals Inc. Common Stock 预报

Supernus Pharmaceuticals Inc. Common Stock 预报: 明天, 下周, 下个月, 5年

已更新: April 22 · 2026 at 07:03 UTC
▼ -4.16%Market Cap $2.82B · Technical analysis Bearish · Focus area Price + volatility

预测总结

大体时间预计价格过去的历史洞察力
明天$49.81 +1.41%昨天$48.83 -0.59%Tomorrow's Supernus Pharmaceuticals Inc. Common Stock (SUPN) setup is anchored to $49.12 and targets $49.81 (+1.41%). The near-term read is upside; watch $50.59 / $47.65 because daily realized volatility is about 7.29%.
Tomorrow's Supernus Pharmaceuticals Inc. Common Stock (SUPN) setup is anchored to $49.12 and targets $49.81 (+1.41%). The near-term read is upside; watch $50.59 / $47.65 because daily realized volatility is about 7.29%.
下周$51.28 +4.40%上星期$48.21 -1.85%The 7-day Supernus Pharmaceuticals Inc. Common Stock model moves from $48.21 to $51.28 (+4.40%). It gives upside momentum context for this stock, so breaks around $50.59 / $47.65 matter more than a single tick.
The 7-day Supernus Pharmaceuticals Inc. Common Stock model moves from $48.21 to $51.28 (+4.40%). It gives upside momentum context for this stock, so breaks around $50.59 / $47.65 matter more than a single tick.
下个月$53.72 +9.37%上个月$47.19 -3.94%The 1-month Supernus Pharmaceuticals Inc. Common Stock target is $53.72 (+9.37%), compared with the live reference near $49.12. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk.
The 1-month Supernus Pharmaceuticals Inc. Common Stock target is $53.72 (+9.37%), compared with the live reference near $49.12. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk.
明年$57.38 +16.82%去年$45.65 -7.07%The 1-year Supernus Pharmaceuticals Inc. Common Stock scenario points to $57.38 (+16.82%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates.
The 1-year Supernus Pharmaceuticals Inc. Common Stock scenario points to $57.38 (+16.82%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates.
5年$65.96 +34.29%5年前$42.05 -14.40%The 5-year Supernus Pharmaceuticals Inc. Common Stock view is $65.96 (+34.29%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path.
The 5-year Supernus Pharmaceuticals Inc. Common Stock view is $65.96 (+34.29%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path.
明天$49.81 +1.41%
昨天$48.83 -0.59%
Tomorrow's Supernus Pharmaceuticals Inc. Common Stock (SUPN) setup is anchored to $49.12 and targets $49.81 (+1.41%). The near-term read is upside; watch $50.59 / $47.65 because daily realized volatility is about 7.29%.
下周$51.28 +4.40%
上星期$48.21 -1.85%
The 7-day Supernus Pharmaceuticals Inc. Common Stock model moves from $48.21 to $51.28 (+4.40%). It gives upside momentum context for this stock, so breaks around $50.59 / $47.65 matter more than a single tick.
下个月$53.72 +9.37%
上个月$47.19 -3.94%
The 1-month Supernus Pharmaceuticals Inc. Common Stock target is $53.72 (+9.37%), compared with the live reference near $49.12. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk.
明年$57.38 +16.82%
去年$45.65 -7.07%
The 1-year Supernus Pharmaceuticals Inc. Common Stock scenario points to $57.38 (+16.82%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates.
5年$65.96 +34.29%
5年前$42.05 -14.40%
The 5-year Supernus Pharmaceuticals Inc. Common Stock view is $65.96 (+34.29%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path.
Risk notice:This forecast is informational only, not financial advice; accuracy depends on volatility, liquidity, macro events, and other external factors.

价格走势图

历史预报看涨看跌
$52.31$51.02$49.72$48.43$47.131W AgoNow7D F

技术分析

中性的
Neutral
1
看涨
3
中性的
1
看跌

关键指标

指标价值信号
Price$49.12 Mid
Daily Change-4.16% Below
Volatility Cap20.0% Mid
Confidence66% Above
Data Sourcenasdaq-screener Mid

史料

Current$49.12
Daily Change-4.16%
Market Cap$2.82B
Sourcenasdaq-screener
Current$49.12Daily Change-4.16%
Market Cap$2.82BSourcenasdaq-screener

支撑位和阻力位

$47.65Support 1
$49.12当前
$50.59Resistance 1
shield
Support and resistance are estimated from the trusted current price until deeper historical data is available.

价格里程碑

关键层面和历史背景
Current$49.12Live reference price
Used as the anchor for generated forecast calculations.
Next Month$53.72Model projection+9.37%
Directional scenario based on capped drift.

预测准确度

我们的模型表现如何
66%
定向
Generated market-data forecast
This page uses live catalog market data and conservative volatility caps. It is informational, not financial advice.
📊
我们的算法每周使用最新的价格行为、波动机制和指标信号进行重新校准。准确性因时间范围而异——短期势头比长期预测更可靠。
Short term
66%
Direction confidence
Long term
Lower
Forecast uncertainty rises with horizon

投资场景

如果您今天投资 $1,000 于 SUPN
Bullish Scenario
$51.58
+5.00% from current
目标价格$51.58
设想Upside momentum
可能性58%
Base Scenario
$53.72
+9.37%
目标价格$53.72
设想Capped drift
可能性66%
Bearish Scenario
$46.66
-5.00% from current
目标价格$46.66
设想Volatility drawdown
可能性34%
基础: Scenario model combines current spot price, recent market direction, and conservative asset-class volatility caps.

预测因素

Market Structure
Price structure reflects the latest momentum regime and support/resistance interaction.
Momentum Bullish · 70/100
24H drift+1.41%
7D drift+4.40%
30D drift+9.37%
Technical Signals
Signals combine RSI, MACD, and moving average stacks to estimate short-term direction.
Mixed — Watching · 50/100
RSIn/a
MACDn/a
MA stackn/a
Macro Context
Rates, dollar strength, and cross-asset risk appetite influence medium-term paths.
Risk-On Tentative · 67/100
1M outlook+9.37%
1Y outlook+16.82%
5Y outlook+34.29%

常见问题解答

Q What is the Supernus Pharmaceuticals Inc. Common Stock (SUPN) forecast for tomorrow?
Using the latest BeCoin market snapshot (April 22 · 2026 at 07:03 UTC), Supernus Pharmaceuticals Inc. Common Stock is projected near $49.81 versus the current reference around $49.12. That implies a modeled move of +1.41% over the next day, with realized prices still sensitive to intraday volatility.
Q What does the 7-day stock outlook suggest for SUPN?
The weekly Supernus Pharmaceuticals Inc. Common Stock model points to $51.28, which maps to an expected drift of +4.40% from current conditions. This horizon reacts quickly to momentum shifts, so support/resistance breaks can change the path faster than long-term targets.
Q How should I read the Supernus Pharmaceuticals Inc. Common Stock 1-month and 1-year targets?
The Supernus Pharmaceuticals Inc. Common Stock 1-month target is $53.72 (+9.37%), while the 1-year target is $57.38 (+16.82%). The monthly view tracks prevailing trend pressure, and the yearly view reflects broader cycle assumptions shaped by price momentum, liquidity, and company-specific risk.
Q Why does the Supernus Pharmaceuticals Inc. Common Stock 5-year scenario differ from short-term rows?
The Supernus Pharmaceuticals Inc. Common Stock long-horizon scenario sits near $65.96 with a modeled change of +34.29%. It compounds cycle-continuation assumptions over time, so it should be treated as a scenario envelope rather than a precise endpoint.
Q Where are SUPN support and resistance zones right now?
For Supernus Pharmaceuticals Inc. Common Stock, nearest resistance is around $47.65, while nearest support is around $50.59. A clean break above resistance improves continuation odds, while repeated closes under support raise downside risk.
Q How fresh is the Supernus Pharmaceuticals Inc. Common Stock market snapshot?
The displayed stock snapshot is labeled April 22 · 2026 at 07:03 UTC; the latest observed session range is roughly n/a to n/a. These checkpoints are rebuilt from the market feed so the FAQ, milestones, and support/resistance context stay tied to the same data refresh.